Unnamed: 0,title,date,stock,sentiment
1068422.0,"RENN Fund Reports Recipt of Non-Binding Bid from Etude CApital, No Terms Disclosed",2016-06-28 13:53:00-04:00,RCG,negative
1068423.0,Revance Therapeutics Shares Halted News Pending,2016-06-13 16:00:00-04:00,RCG,positive
1068424.0,"Etude Capital Delivers Letter to RENN Fund CEO, Board of Directors",2016-06-13 14:47:00-04:00,RCG,neutral
1068425.0,Etude Capital Liquidates 11.4% Stake In RENN Fund,2016-04-07 08:02:00-04:00,RCG,neutral
1068426.0,The Big 4 Theatre Stocks Underperformed In 2015...Will This Year Be Better?,2016-01-11 13:05:00-05:00,RCG,positive
